FDA Inspection 1110454 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on November 4, 2019 in Grand Prairie, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Grand Prairie, TX (United States)